written on 28.04.2014

UPDATED: Merck could snag $14B from consumer biz as Bayer, Reckitt race to the wire


Merck has entered the home stretch with its consumer unit sale, and the deal may be even bigger than previous reports have hinted. According to <em>Reuters</em>, the unit could go for close to $14 billion–a number that could climb even higher as front-runners Bayer and Reckitt Benckiser duke it out.